Brigatinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso CAS No:NA chemically represented as N-(5-Chloro-4-((2-(dimethylphosphoryl)phenyl)amino)pyrimidin-2-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso . We supply Brigatinib Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144051 |
| CAS No | NA |
| Mol.F. | C18H20FN7O6 |
| Mol.Wt. | 449.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144052 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144053 |
| CAS No | NA |
| Mol.F. | C8H11N5O4 |
| Mol.Wt. | 241.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144054 |
| CAS No | NA |
| Mol.F. | C9H8FN3O3 |
| Mol.Wt. | 225.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144055 |
| CAS No | NA |
| Mol.F. | C17H18N4O7 |
| Mol.Wt. | 390.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144056 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144057 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144058 |
| CAS No | NA |
| Mol.F. | C23H22FN5O6 |
| Mol.Wt. | 483.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144059 |
| CAS No | NA |
| Mol.F. | C24H22FN9O8 |
| Mol.Wt. | 583.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144060 |
| CAS No | NA |
| Mol.F. | C6H9N3O5 |
| Mol.Wt. | 203.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144061 |
| CAS No | NA |
| Mol.F. | C7H13N3O5 |
| Mol.Wt. | 219.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144062 |
| CAS No | NA |
| Mol.F. | C3H5N3O5 |
| Mol.Wt. | 163.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144063 |
| CAS No | NA |
| Mol.F. | C16H19N5O4 |
| Mol.Wt. | 345.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |